Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Lower cognitive function and the presence of obesity and hypertension: The Framingham Heart Study

Department of Mathematics and Statistics, Statistics and Consulting Unit, Boston University, MA 02215, USA.
International Journal of Obesity (Impact Factor: 5). 03/2003; 27(2):260-8. DOI: 10.1038/sj.ijo.802225
Source: PubMed


To determine the independent effects of obesity and hypertension on cognitive functioning.
Using a prospective design, male (n=551) and female (n=872) participants of the Framingham Heart Study were classified by presence or absence of obesity and hypertension based on data collected over an 18-y surveillance period. All subjects were free from dementia, stroke, and clinically diagnosed cardiovascular disease up to the time of cognitive testing. Statistical models were adjusted for age, education, occupation, cigarette smoking, alcohol consumption, total cholesterol, and a diagnosis of type II diabetes. Body mass index status (nonobese or obese) and blood pressure status (normotensive or hypertensive) were then related to cognitive performance (learning, memory, executive functioning, and abstract reasoning) on tests administered 4-6 y later.
Adverse effects of obesity and hypertension on cognitive performance were observed for men only. Obese and hypertensive men performed more poorly than men classified as either obese or hypertensive, and the best performance was observed in nonobese, normotensive men.
The adverse effects of obesity and hypertension in men are independent and cumulative with respect to cognitive deficit.


Available from: Merrill F Elias, May 12, 2014
  • Source
    • "Dementia was defined as a score two or more standard deviations (SD) below the mean on the composite cognitive test score. Similar procedures to diagnose dementia have been reported in other cohorts [29]. Applying this operational definition, 240 participants with dementia at baseline were excluded. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Cognitive impairment is associated with increased mortality. We examined the association between motoric cognitive risk (MCR) syndrome, a predementia syndrome characterized by slow gait and cognitive complaints, and survival. Methods: A total of 11,867 nondemented participants aged >65 years from three established cohort studies in the United States and Europe were screened for MCR. Mortality risk of MCR was assessed with Cox and logistic regression models. Results: At baseline, 836 (7.0%) participants had MCR. Over a median follow-up of 28 months, 1603 participants died (758 in first 2 years). MCR was associated with increased mortality overall (adjusted hazard ratio, 1.69; 95% confidence interval [CI], 1.46-1.96) and 2-year mortality (adjusted odds ratio, 1.89; 95% CI, 1.50-2.38). The association remained after accounting for established mortality risk factors as well as baseline gait speed and memory performance. Discussion: MCR is associated with increased mortality. Older adults should be screened for MCR to identify at-risk individuals for dementia and death.
    Alzheimer's & dementia: the journal of the Alzheimer's Association 11/2015; DOI:10.1016/j.jalz.2015.08.167 · 12.41 Impact Factor
  • Source
    • "A growing body of evidence indicates that cognitive impairment is associated with obesity, metabolic syndrome, and type 2 diabetes (T2D) (Elias et al. 2003; Hassing et al. 2004; Calvo-Ochoa and Arias 2014), suggesting common yet undefined pathogenic mechanisms among the conditions. However, the cellular and molecular mechanisms driving these peripherally induced CNS deficits remain elusive in this emerging area of interest. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Compelling evidence indicates that type 2 diabetes mellitus (T2D), insulin resistance (IR), and metabolic syndrome are often accompanied by cognitive impairment. However, the mechanistic link between these metabolic abnormalities and CNS dysfunction requires further investigations. Here, we evaluated whether adipose tissue (AT) IR and related metabolic alterations resulted in CNS changes by studying synapse lipid composition and function in the adipocyte-specific ecto-nucleotide pyrophosphate phosphodiesterase overexpressing transgenic (AtENPP1-Tg) mouse, a model characterized by white adipocyte IR, systemic IR, and ectopic fat deposition. When fed a high-fat diet (HFD), AtENPP1-Tg mice recapitulate essential features of the human metabolic syndrome, making them an ideal model to characterize peripherally induced CNS deficits. Using a combination of gas chromatography and western blot analysis, we found evidence of altered lipid composition, including decreased phospholipids and increased triglycerides (TG) and fatty acid (FFA) in hippocampal synaptosomes isolated from HFD-fed AtENPP1-Tg mice. These changes were associated with impaired basal synaptic transmission at the Schaffer collaterals to hippocampal cornu ammonis 1 (CA1) synapses, decreased phosphorylation of the GluN1 glutamate receptor subunit, down-regulation of insulin receptor expression and up-regulation of the FFA receptor 1. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Journal of Neurochemistry 02/2015; 133(1). DOI:10.1111/jnc.13043 · 4.28 Impact Factor
  • Source
    • "Recently, our group examined GM changes in structural MRI data from elderly subjects with different degrees of cardiovascular risk (de Toledo Ferraz Alves et al., 2011) using the Framingham Coronary Heart Disease Risk [FCHDR (Grundy et al., 1998; Wilson et al., 1998)] score, a composite index comprising five clinical factors (age, blood pressure, diabetes mellitus, smoking status, and cholesterol levels ). Given recent findings regarding cardiovascular risk effects on cognitive performance (Mosconi, 2005; Obisesan et al., 2008; Fitzpatrick et al., 2009; Purandare, 2009; Scarmeas et al., 2009; Buchman et al., 2012), the FCHDR score has presented excellent potential for investigations involving brain imaging (Elias et al., 2003; Jeerakathil et al., 2004; Massaro et al., 2004; Seshadri et al., 2004; DeCarli et al., 2005; Romero et al., 2009). For the study by de Toledo Ferraz Alves et al. (2011), dementiafree individuals aged from 66 to 75 years were recruited from the database " São Paulo Aging and Health Study " (SPAH) (Scazufca and Seabra, 2008; Scazufca et al., 2008) and divided into three subgroups (high-risk, medium-risk, and low-risk) according to their FCHDR scores and gender (Table 1). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent literature has presented evidence that cardiovascular risk factors (CVRF) play an important role on cognitive performance in elderly individuals, both those who are asymp-tomatic and those who suffer from symptoms of neurodegenerative disorders. Findings from studies applying neuroimaging methods have increasingly reinforced such notion. Studies addressing the impact of CVRF on brain anatomy changes have gained increasing importance, as recent papers have reported gray matter loss predominantly in regions traditionally affected in Alzheimer's disease (AD) and vascular dementia in the presence of a high degree of cardiovascular risk. In the present paper, we explore the association between CVRF and brain changes using pattern recognition techniques applied to structural MRI and the Framingham score (a composite measure of cardiovascular risk largely used in epidemiological studies) in a sample of healthy elderly individuals. We aim to answer the following questions: is it possible to decode (i.e., to learn information regarding cardio-vascular risk from structural brain images) enabling individual predictions? Among clinical measures comprising the Framingham score, are there particular risk factors that stand as more predictable from patterns of brain changes? Our main findings are threefold: (i) we verified that structural changes in spatially distributed patterns in the brain enable statistically significant prediction of Framingham scores. This result is still significant when controlling for the presence of the APOE 4 allele (an important genetic risk factor for both AD and cardiovascular disease). (ii) When considering each risk factor singly, we found different levels of correlation between real and predicted factors; however, single factors were not significantly predictable from brain images when considering APOE4 allele presence as covariate. (iii) We found important gender differences, and the possible causes of that finding are discussed.
    Frontiers in Aging Neuroscience 12/2014; 6(300). DOI:10.3389/fnagi.2014.00300 · 4.00 Impact Factor
Show more